apnimed.com/article/ad109toplinephase3results

Preview meta tags from the apnimed.com website.

Linked Hostnames

5

Thumbnail

Search Engine Appearance

Google

https://apnimed.com/article/ad109toplinephase3results

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea - Apnimed

Apnimed releases positive topline Phase 3 results for LunAIRo, the second Phase 3 clinical trial of AD109, meeting its primary endpoint, highlighting that AD109 met the primary endpoint, demonstrating a reduction in apnea-hypopnea index (AHI, p



Bing

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea - Apnimed

https://apnimed.com/article/ad109toplinephase3results

Apnimed releases positive topline Phase 3 results for LunAIRo, the second Phase 3 clinical trial of AD109, meeting its primary endpoint, highlighting that AD109 met the primary endpoint, demonstrating a reduction in apnea-hypopnea index (AHI, p



DuckDuckGo

https://apnimed.com/article/ad109toplinephase3results

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea - Apnimed

Apnimed releases positive topline Phase 3 results for LunAIRo, the second Phase 3 clinical trial of AD109, meeting its primary endpoint, highlighting that AD109 met the primary endpoint, demonstrating a reduction in apnea-hypopnea index (AHI, p

  • General Meta Tags

    14
    • title
      Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea - Apnimed
    • charset
      UTF-8
    • viewport
      width=device-width, initial-scale=1
    • target
      all
    • audience
      all

  • Open Graph Meta Tags

    10
    • US country flagog:locale
      en_US
    • og:type
      article
    • og:title
      Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea - Apnimed
    • og:description
      Apnimed releases positive topline Phase 3 results for LunAIRo, the second Phase 3 clinical trial of AD109, meeting its primary endpoint, highlighting that AD109 met the primary endpoint, demonstrating a reduction in apnea-hypopnea index (AHI, p
    • og:url
      https://apnimed.com/article/ad109toplinephase3results/

  • Twitter Meta Tags

    4
    • twitter:card
      summary_large_image
    • twitter:site
      @apnimed
    • twitter:label1
      Est. reading time
    • twitter:data1
      7 minutes

  • Link Tags

    34
    • EditURI
      https://apnimed.com/xmlrpc.php?rsd
    • alternate
      https://apnimed.com/feed/
    • alternate
      https://apnimed.com/comments/feed/
    • alternate
      https://apnimed.com/wp-json/wp/v2/news/1469
    • alternate
      https://apnimed.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fapnimed.com%2Farticle%2Fad109toplinephase3results%2F

Links

26